SS
GMAB icon

SBI Securities’s Genmab GMAB Stock Holding History

SBI Securities’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.48K Sell
236
-134
-36% -$3.56K ﹤0.01% 2058
2026
Q1 		$9.93K Sell
370
-1,894
-84% -$56.8K ﹤0.01% 1718
2025
Q4 		$69.7K Buy
2,264
+1,952
+626% +$60.8K ﹤0.01% 962
2025
Q3 		$9.57K Buy
312
+5
+2% +$122 ﹤0.01% 1791
2025
Q2 		$6.34K Buy
307
+91
+42% +$1.87K ﹤0.01% 1879
2025
Q1 		$4.23K Buy
216
+33
+18% +$692 ﹤0.01% 1966
2024
Q4 		$3.82K Buy
+183
New +$4.02K ﹤0.01% 2024

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

SBI Securities's GMAB Position: Q2 2026 in Review

SBI Securities reduced its Genmab (GMAB) stake by 36% in Q2 2026, selling an estimated $3.56K and leaving 236 shares worth $6.48K. The position accounts for ﹤0.01% of the portfolio, ranked #2058.

SBI Securities first reported a position in GMAB in Q4 2024 and has held it in 7 quarters since. The position peaked at $69.7K in Q4 2025. 289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • SBI Securities held 236 shares of Genmab worth $6.48K as of Q2 2026.
  • SBI Securities sold 134 Genmab shares in Q2 2026, an estimated $3.56K.
  • Genmab made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2058 holding.
  • SBI Securities first reported a position in Genmab in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Genmab position peaked at $69.7K in Q4 2025.
  • 289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.